Tilray Inc (NASDAQ:TLRY) Shares Purchased by Marathon Trading Investment Management LLC

Marathon Trading Investment Management LLC raised its position in Tilray Inc (NASDAQ:TLRY) by 439.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 240,400 shares of the company’s stock after acquiring an additional 195,800 shares during the quarter. Marathon Trading Investment Management LLC’s holdings in Tilray were worth $320,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Ferguson Wellman Capital Management Inc. purchased a new position in shares of Tilray in the third quarter valued at approximately $26,000. Verdence Capital Advisors LLC purchased a new stake in Tilray during the 4th quarter worth approximately $29,000. Ameritas Advisory Services LLC acquired a new stake in Tilray during the 4th quarter worth approximately $32,000. Newman Dignan & Sheerar Inc. boosted its position in Tilray by 61.9% in the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company’s stock valued at $35,000 after buying an additional 10,000 shares during the period. Finally, Jones Financial Companies Lllp grew its stake in shares of Tilray by 125.7% in the fourth quarter. Jones Financial Companies Lllp now owns 31,725 shares of the company’s stock worth $42,000 after acquiring an additional 17,670 shares in the last quarter. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group increased their price objective on Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a research note on Monday, January 13th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $2.70.

Tilray Trading Down 6.2 %

NASDAQ TLRY opened at $0.65 on Tuesday. The stock has a market capitalization of $610.04 million, a PE ratio of -2.17 and a beta of 2.13. The firm has a 50 day moving average of $1.04 and a two-hundred day moving average of $1.37. Tilray Inc has a 52 week low of $0.63 and a 52 week high of $2.97. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10.

Tilray (NASDAQ:TLRY) last released its quarterly earnings data on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The business had revenue of $210.90 million for the quarter, compared to analyst estimates of $216.34 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. As a group, research analysts expect that Tilray Inc will post -0.2 EPS for the current fiscal year.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.